<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04332445</url>
  </required_header>
  <id_info>
    <org_study_id>HB032-19</org_study_id>
    <nct_id>NCT04332445</nct_id>
  </id_info>
  <brief_title>Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.</brief_title>
  <official_title>Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herbarium Laboratorio Botanico Ltda</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herbarium Laboratorio Botanico Ltda</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical study for health care product safety assessment. The research is going to&#xD;
      conducted with 55 subjects, aged 18 to 70 years. The product is applied on the right and/or&#xD;
      left participant back. After a wash out, the product is reapplied. Medical evaluation will be&#xD;
      available throughout the study to assess possible adverse events. The main of the study is to&#xD;
      observe the effects of the application of the product on the skin and prove the absence of&#xD;
      irritability and/or allergy, photoallergy and phototoxicity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects phototypes I to IV (according to Fitzpatrick classification). The products is&#xD;
      applied over semi-occlusive dressings, remaing in contact with the skin.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 26, 2020</start_date>
  <completion_date type="Actual">December 3, 2020</completion_date>
  <primary_completion_date type="Actual">December 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Clinical trial, single-arm</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Erythema degree or absence</measure>
    <time_frame>39 days</time_frame>
    <description>Erythema evaluation according to International Contact Dermatitis Research Group</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Sensitivity, Contact</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects, 18-70 y, healthy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyaluronic Acid Gel</intervention_name>
    <description>Health care product - to be apllied on the subject's skin</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy participants;&#xD;
&#xD;
          -  Non-injured skin in the test region;&#xD;
&#xD;
          -  Agreement to adhere to the test procedures and requirements and to attend the&#xD;
             institute on the day(s) and at the time(s) determined for the evaluations;&#xD;
&#xD;
          -  Ability to consent to participation in the study;&#xD;
&#xD;
          -  Phototype (Fitzpatrick): II and III;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breastfeeding women;&#xD;
&#xD;
          -  Use of the following systemic drugs: antihistamines, non-hormonal anti-inflammatory&#xD;
             drugs and corticoids;&#xD;
&#xD;
          -  History of allergy to cosmetics, topical products or research product;&#xD;
&#xD;
          -  Localized or widespread dermatological diseases or inflammatory dermatoses active and&#xD;
             nerve damage in the test region;&#xD;
&#xD;
          -  Personal or family pathological history of skin cancer;&#xD;
&#xD;
          -  Use of topical or systemic photosensitizing medication;&#xD;
&#xD;
          -  History of phototoxic, photoallergic reactions, dermatoses caused by light, atopy,&#xD;
             pathologies aggravated or triggered by ultraviolet radiation;&#xD;
&#xD;
          -  Photo-induced pathologies;&#xD;
&#xD;
          -  Frequent exposure to the sun or tanning chambers;&#xD;
&#xD;
          -  Participated in an allergenicity study in a period of less than 4 weeks from the start&#xD;
             of the study;&#xD;
&#xD;
          -  Skin marks in the experimental area that interfere with the evaluation of possible&#xD;
             reactions;&#xD;
&#xD;
          -  Active dermatoses;&#xD;
&#xD;
          -  Forecast to take a bath in the sea, pool or sauna during the study;&#xD;
&#xD;
          -  Participants who play water sports;&#xD;
&#xD;
          -  Dermography;&#xD;
&#xD;
          -  Use of the following topical or systemic drugs: immunosuppressants, antihistamines,&#xD;
             non-hormonal anti-inflammatory drugs and corticoids up to 2 weeks prior to selection&#xD;
             or, considering deposit corticoids, the interval shall be 1 month prior to selection;&#xD;
&#xD;
          -  Treatment with acid vitamin A and/or its derivatives via oral or topical until&#xD;
&#xD;
             1 month before the beginning of the study;&#xD;
&#xD;
          -  Aesthetic and/or body dermatological treatment until 3 weeks before selection;&#xD;
&#xD;
          -  Vaccination during the study or until 3 weeks before the study;&#xD;
&#xD;
          -  Being participated in another clinical trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kosmoscience Ciência e Tecnologia Cosmética Ltda</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13041-315</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 27, 2020</study_first_submitted>
  <study_first_submitted_qc>April 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2020</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis, Phototoxic</mesh_term>
    <mesh_term>Dermatitis, Photoallergic</mesh_term>
    <mesh_term>Dermatitis, Contact</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

